227 related articles for article (PubMed ID: 24848581)
1. A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease.
Goldstein DS; Sullivan P; Holmes C; Miller GW; Sharabi Y; Kopin IJ
J Neurochem; 2014 Oct; 131(2):219-28. PubMed ID: 24848581
[TBL] [Abstract][Full Text] [Related]
2. Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.
Goldstein DS; Holmes C; Sullivan P; Mash DC; Sidransky E; Stefani A; Kopin IJ; Sharabi Y
Parkinsonism Relat Disord; 2015 Sep; 21(9):1013-22. PubMed ID: 26255205
[TBL] [Abstract][Full Text] [Related]
3. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.
Taylor TN; Alter SP; Wang M; Goldstein DS; Miller GW
Neuropharmacology; 2014 Jan; 76 Pt A(0 0):97-105. PubMed ID: 24025942
[TBL] [Abstract][Full Text] [Related]
4. Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
Goldstein DS; Sullivan P; Holmes C; Kopin IJ; Sharabi Y; Mash DC
Parkinsonism Relat Disord; 2015 Jun; 21(6):567-72. PubMed ID: 25829070
[TBL] [Abstract][Full Text] [Related]
5. Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.
Pifl C; Rajput A; Reither H; Blesa J; Cavada C; Obeso JA; Rajput AH; Hornykiewicz O
J Neurosci; 2014 Jun; 34(24):8210-8. PubMed ID: 24920625
[TBL] [Abstract][Full Text] [Related]
6. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.
Goldstein DS; Sullivan P; Holmes C; Miller GW; Alter S; Strong R; Mash DC; Kopin IJ; Sharabi Y
J Neurochem; 2013 Sep; 126(5):591-603. PubMed ID: 23786406
[TBL] [Abstract][Full Text] [Related]
7. Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases.
Goldstein DS; Holmes C; Kopin IJ; Sharabi Y
J Clin Invest; 2011 Aug; 121(8):3320-30. PubMed ID: 21785221
[TBL] [Abstract][Full Text] [Related]
8. Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy.
Goldstein DS; Sullivan P; Holmes C; Mash DC; Kopin IJ; Sharabi Y
Parkinsonism Relat Disord; 2017 Feb; 35():88-91. PubMed ID: 28034624
[TBL] [Abstract][Full Text] [Related]
9. Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.
Goldstein DS; Kopin IJ; Sharabi Y; Holmes C
Clin Auton Res; 2015 Feb; 25(1):61-7. PubMed ID: 25638582
[TBL] [Abstract][Full Text] [Related]
10. The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases.
Goldstein DS
Semin Neurol; 2020 Oct; 40(5):502-514. PubMed ID: 32906170
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.
Jain S; Goldstein DS
Neurobiol Dis; 2012 Jun; 46(3):572-80. PubMed ID: 22094370
[TBL] [Abstract][Full Text] [Related]
12. Does sympathetic dysfunction occur before denervation in pure autonomic failure?
Guo L; Esler MD; Sari C; Phillips S; Lambert EA; Straznicky NE; Lambert GW; Corcoran SJ
Clin Sci (Lond); 2018 Jan; 132(1):1-16. PubMed ID: 29162745
[TBL] [Abstract][Full Text] [Related]
13. The heart of PD: Lewy body diseases as neurocardiologic disorders.
Goldstein DS; Sharabi Y
Brain Res; 2019 Jan; 1702():74-84. PubMed ID: 29030055
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson's disease: a post-mortem observational study.
Isonaka R; Sullivan P; Goldstein DS
Transl Neurodegener; 2022 Mar; 11(1):15. PubMed ID: 35260194
[TBL] [Abstract][Full Text] [Related]
15. Cardiac sympathetic innervation and vesicular storage in pure autonomic failure.
Goldstein DS; Isonaka R; Holmes C; Ding YS; Sharabi Y
Ann Clin Transl Neurol; 2020 Oct; 7(10):1908-1918. PubMed ID: 32945121
[TBL] [Abstract][Full Text] [Related]
16. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
17. The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease.
Landau R; Halperin R; Sullivan P; Zibly Z; Leibowitz A; Goldstein DS; Sharabi Y
Dis Model Mech; 2022 Jan; 15(1):. PubMed ID: 34842277
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers, mechanisms, and potential prevention of catecholamine neuron loss in Parkinson disease.
Goldstein DS
Adv Pharmacol; 2013; 68():235-72. PubMed ID: 24054148
[TBL] [Abstract][Full Text] [Related]
19. Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.
Isingrini E; Guinaudie C; C Perret L; Rainer Q; Moquin L; Gratton A; Giros B
Sci Rep; 2017 Sep; 7(1):12432. PubMed ID: 28963508
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure.
Kimura K; Kanazawa H; Ieda M; Kawaguchi-Manabe H; Miyake Y; Yagi T; Arai T; Sano M; Fukuda K
Auton Neurosci; 2010 Aug; 156(1-2):27-35. PubMed ID: 20335077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
